{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Camptothecin",
  "nciThesaurus": {
    "casRegistry": "7689-03-4",
    "chebiId": "CHEBI:27656",
    "chemicalFormula": "C20H16N2O4",
    "definition": "An alkaloid isolated from the Chinese tree Camptotheca acuminata, with antineoplastic activity.  During the S phase of the cell cycle, camptothecin selectively stabilizes topoisomerase I-DNA covalent complexes, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. (NCI)",
    "fdaUniiCode": "XT3Z54Z28A",
    "identifier": "C338",
    "preferredName": "Camptothecin",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1904"
    ],
    "synonyms": [
      "(+)-Camptothecin",
      "(S)-4-ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolozino[1,2-b]quinoline-3,14(4H,12H)-dione",
      "1H-Pyrano[3',3'.6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4hydroxy-(S)-(9CI)",
      "20(S)-Camptothecine",
      "20-(S)-camptothecine",
      "21, 22-Secocamptothecin-21-oic acid lactone",
      "21, 22-secocamptothecin-21-oic acid lactone",
      "CAMPTOTHECIN",
      "Camptothecin",
      "camptothecin",
      "camptothecine"
    ]
  }
}